Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Robotic 3D Ultrasound System Improves Accuracy of Liver Cancer Treatment

By HospiMedica International staff writers
Posted on 27 Jan 2023

Liver cancer is the fourth-leading cause of cancer death in the world. More...

Surgery is one treatment option for liver cancer, although thermal ablation which uses heat to destroy the cancerous tumor has less complications and a quicker recovery time. It can also be performed on patients who are not fit for surgery due to some reasons. However, thermal ablation requires precise needle placement to treat the cancer without damaging the vital organs and blood vessels surrounding it. Now, a new system that uses ultrasound to construct 3D-images could increase the accuracy of thermal ablation for treating liver cancer.

Generally, ultrasound or CT (computerized tomography) imaging is used to guide needle placement, although both are limited. Although ultrasound is widely available and can be performed in real-time, it delivers only 2D images. On the other hand, a CT scan generates 3D images, but not in real time and is a lengthy process. In order to create 3D ultrasound images, the new system uses a robotic cradle to move a standard ultrasound probe, collecting images and stacking them like puzzle pieces. In a simulated study, researchers at Western University (Ontario, Canada) and Lawson Health Research Institute (Ontario, Canada) used data from 14 patient cases to analyze the technology’s accuracy. They found that with standard imaging, there was complete tumor ablation in 64.3% of cases, while the new system offered complete coverage for 92.9% of cases (13 out of 14 cases). They found that in the one remaining case, the patient could benefit from increased ablation time or intensity. If the robotic ultrasound system proves to be effective, then its portability could enable more widespread use of 3D ultrasound imaging, such as in smaller health care centers. Additionally, it could also reduce imaging wait times by eliminating the need for CT scans.

“We developed a new 3D ultrasound method that shows promise in analyzing whether the complete liver tumor will be ablated by the procedure,” explained Aaron Fenster, professor at Schulich Medicine & Dentistry and scientist at Robarts Research Institute. “And we’re now using the same system to guide the needle directly into the centre of the tumor.”

Related Links:
Western University
Lawson Health Research Institute 


Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Ultrasound System
FUTUS LE
X-Ray Meter
Cobia SENSE
Digital X-Ray Detector Panel
Acuity G4
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.